GDTC

CYTOMED THERAPEUTICS LIMITED

GDTC·Y1R80M106·US·Common Stock·Healthcare - Biotechnology-Activist

GDTC (CYTOMED THERAPEUTICS LIMITED) is held by 2 institutional investors as of Q2 2026. Largest holders: UBS Group AG ($4,976), OSAIC HOLDINGS, INC. ($21). Net institutional sentiment: Bearish.

2
Holders
$4,997
Total Value
0% (2)
Consensus
0 buying - 2 selling
13F: Insider & Congress: Updated regularly
GDTC

Smart Money Verdict

View all
Loading verdict
Held by 2 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jul 24, 2026 · Activists Jul 24, 2026 · Congress none

ActivistCCChoo Chee Kong24.3%Jul 24, 2026
InsiderCKChoo Chee KongBuy $150KJul 20, 2026
InsiderCKChoo Chee KongBuy $150KJul 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
4,831(-21.9%)$4,9760.0%-25.47%
0
Unchanged
21$210.0%-29.31%
0
Exited
0(-100.0%)$10,1360.0%-1.90%
0
GDTCGDTCCYTOMED THERAPEUTICS LIMITED

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used